As of Jan 19
| -0.0099 / -1.08%|
The 2 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +9.89% increase from the last price of 0.91.
The current consensus among 4 polled investment analysts is to Hold stock in Opexa Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.